Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Traphaco JSC's change in receivables for the quarter that ended in Jun. 2026 was ₫-651 Mil. It means Traphaco JSC's Accounts Receivable
increased by ₫651 Mil
from Mar. 2026 to Jun. 2026 .
Traphaco JSC's change in receivables for the fiscal year that ended in Dec. 2025 was ₫-172,274 Mil. It means Traphaco JSC's Accounts Receivable
increased by ₫172,274 Mil
from Dec. 2024 to Dec. 2025 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Traphaco JSC's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 47.96.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Traphaco JSC's liquidation value for the
three
months ended in Jun. 2026 was ₫491,173 Mil.
Traphaco JSC (STC:TRA) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Traphaco JSC's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Traphaco JSC Change In Receivables Related Terms
Traphaco JSC Change In Receivables Historical Data
* Premium members only.
The historical data trend for Traphaco JSC's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫-78,761 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of ₫-78,761 Mil mean?
Traphaco JSC (STC:TRA) has a Change In Receivables of ₫-78,761 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Traphaco JSC and its competitors.
Is Traphaco JSC's Change In Receivables too high?
Traphaco JSC's current Change In Receivables is ₫-78,761 Mil. Overall, Traphaco JSC has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Traphaco JSC's Change In Receivables compare to ZTS?
Traphaco JSC's Change In Receivables of ₫-78,761 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Traphaco JSC and its competitors. Traphaco JSC's current Change In Receivables is ₫-78,761 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Traphaco JSC stock overvalued right now?
Based on GuruFocus' analysis, Traphaco JSC (STC:TRA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫45,773.47, compared to a current price of ₫37,000.00 — trading 19.2% below its estimated fair value. The current Change In Receivables is ₫-78,761 Mil. Traphaco JSC's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Traphaco JSC (STC:TRA), the current Change In Receivables is ₫-78,761 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Traphaco JSC (STC:TRA) Overvalued in 2026?
Based on GuruFocus' analysis, Traphaco JSC stock appears to be undervalued.
The current stock price of ₫37,000.00 is trading 19.2% below its estimated GF Value™ of ₫45,773.47.
GuruFocus considers Traphaco JSC to be Modestly Undervalued.
Key valuation signals for STC:TRA:
Change In Receivables: ₫-78,761 Mil
GF Value™: ₫45,773.47 vs. price of ₫37,000.00 (19.2% below fair value)
No single metric tells the full story. See the STC:TRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Traphaco JSC is engaged in the production and trading of pharmaceuticals, chemicals, and medical supplies and equipment. The company's products are used for nourishing the body, the Skeletal system, for hair, for eyes, the Nervous system, the Respiratory system, and Other groups.
83GF Score
Get the complete analysis for STC:TRA
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:TRA has been successfully added to your 
